Halo Biosciences ("Halo"), a clinical-stage biotechnology company developing extracellular matrix-targeted therapies, today announced publication of results from the Phase 2a SATURN study in Thorax.

AI message decidedly topical while its themes grapple with dual visions of reality.There's been a host of so-called immersive ambitions to alter the moviegoing experience over the decades, be it the ...

The Nothing Phone (3) is launching on the 2nd of July, and could come with a brand new LED matrix rear display, replacing its ...